Literature DB >> 9864247

Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.

M E Munk1, P Anding, A P Schettini, M G Cunha, S H Kaufmann.   

Abstract

Serum levels of soluble tumor necrosis factor alpha receptor I (sTNF-RI) were elevated in patients with lepromatous (LL) reactional-state type II leprosy, and sTNF-RII levels were increased in patients with full tuberculoid (TT) or LL type II leprosy. The sTNF-R in sera from patients with type II leprosy, but not other forms of leprosy, inhibited recombinant TNF cytolytic activities in vitro. This suggests that sTNF-R regulatory activities are partially impaired in patients with leprosy.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9864247      PMCID： PMC96328     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.

Authors:  W Fiers
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

2.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

3.  Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.

Authors:  E N Sarno; G E Grau; L M Vieira; J A Nery
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

6.  Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils.

Authors:  F Porteu; M Brockhaus; D Wallach; H Engelmann; C F Nathan
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

7.  Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.

Authors:  H Loetscher; R Gentz; M Zulauf; A Lustig; H Tabuchi; E J Schlaeger; M Brockhaus; H Gallati; M Manneberg; W Lesslauer
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

8.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.

Authors:  E Girardin; P Roux-Lombard; G E Grau; P Suter; H Gallati; J M Dayer
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Authors:  K J Van Zee; T Kohno; E Fischer; C S Rock; L L Moldawer; S F Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

10.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

Authors:  D Aderka; H Engelmann; Y Maor; C Brakebusch; D Wallach
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307
View more
  4 in total

Review 1.  Serological markers of disease activity in tuberculosis and HIV infection.

Authors:  A Marchant
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.

Authors:  Alaa Sabry; Sherief Refat Elbasyouni; Hussein A Sheashaa; Amr A Alhusseini; Khaled Mahmoud; Shahir Kamal George; Ehab Abdel Kaleek; Hamdy abo-Zena; Abdalla M Kalil; Tareek Mohsen; Mona Abdel Rahim; Ayman Z El-samanody
Journal:  Int Urol Nephrol       Date:  2007-01-27       Impact factor: 2.370

3.  Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.

Authors:  Rosane Dias Costa; Vanessa Amaral Mendonça; Frederico Marianetti Soriani; Sandra Lyon; Rachel Adriana Penido; Ana Maria Duarte Dias Costa; Marina Dias Costa; Fabio de Souza Terra; Mauro Martins Teixeira; Carlos Mauricio de Figueiredo Antunes; Antonio Lúcio Teixeira
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

4.  Biological agents: investigation into leprosy and other infectious diseases before indication.

Authors:  João Roberto Antônio; Rosa Maria Cordeiro Soubhia; Vania Del Arco Paschoal; Carolina Forte Amarante; Ana Regina Franchi Travolo
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.